1-11 of 11
Jo-Ann I. Sheppard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard, Lori-Ann Linkins, Donald M. Arnold, Ishac Nazy
Journal: Blood
Blood (2018) 132 (12): 1345–1349.
https://doi.org/10.1182/blood-2018-04-847483
Published: 2018
Journal Articles

Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma

Hira Mian, Theodore E. Warkentin, Jo-Ann I. Sheppard, Anna MacDonald, Lori-Ann Linkins, Ann Benger, Ronan Foley
Journal: Blood
Blood (2017) 130 (14): 1679–1682.
https://doi.org/10.1182/blood-2017-06-788679
Published: 2017
Journal Articles

Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities

Brief Report
Theodore E. Warkentin, Jo-Ann I. Sheppard, F. Victor Chu, Anil Kapoor, Mark A. Crowther, Azim Gangji
Journal: Blood
Blood (2015) 125 (1): 195–198.
https://doi.org/10.1182/blood-2014-07-590844
Published: 2015
Journal Articles

Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard
Journal: Blood
Blood (2014) 123 (16): 2485–2493.
https://doi.org/10.1182/blood-2013-10-533083
Published: 2014
Journal Articles

Studies of the immune response in heparin-induced thrombocytopenia

Theodore E. Warkentin, Jo-Ann I. Sheppard, Jane C. Moore, Richard J. Cook, John G. Kelton
Journal: Blood
Blood (2009) 113 (20): 4963–4969.
https://doi.org/10.1182/blood-2008-10-186064
Published: 2009
Includes: Supplemental data
Journal Articles

The temporal profile of the anti-PF4/heparin immune response

Andreas Greinacher, Thomas Kohlmann, Ulrike Strobel, Jo-Ann I. Sheppard, Theodore E. Warkentin
Journal: Blood
Blood (2009) 113 (20): 4970–4976.
https://doi.org/10.1182/blood-2008-08-173062
Published: 2009
Journal Articles

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard, Christopher S. Sigouin, Thomas Kohlmann, Petra Eichler, Andreas Greinacher
Journal: Blood
Blood (2006) 108 (9): 2937–2941.
https://doi.org/10.1182/blood-2005-11-012450
Published: 2006
Journal Articles

Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

Clinical Trials & Observations
Theodore E. Warkentin, Richard J. Cook, Victor J. Marder, Jo-Ann I. Sheppard, Jane C. Moore, Bengt I. Eriksson, Andreas Greinacher, John G. Kelton
Journal: Blood
Blood (2005) 106 (12): 3791–3796.
https://doi.org/10.1182/blood-2005-05-1938
Published: 2005
Journal Articles

Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.

Theodore E. Warkentin, MD, Jo-Ann I. Sheppard, Jane C. Moore, Kathleen M. Moore, Christopher S. Sigouin, John G. Kelton, MD
Journal: Blood
Blood (2004) 104 (11): 3022.
https://doi.org/10.1182/blood.V104.11.3022.3022
Published: 2004
Journal Articles

Argatroban Inhibits Human Factor Xa at Therapeutic Drug Levels: An Explanation for Its Prolongation of the INR.

Theodore E. Warkentin, MD, Andreas Greinacher, MD, Sharon Craven, Lori Dewar, Jo-Ann I. Sheppard, Frederick A. Ofosu, PhD
Journal: Blood
Blood (2004) 104 (11): 1845.
https://doi.org/10.1182/blood.V104.11.1845.1845
Published: 2004
Journal Articles

Impact of the patient population on the risk for heparin-induced thrombocytopenia

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard, Peter Horsewood, Patricia J. Simpson, Jane C. Moore, John G. Kelton
Journal: Blood
Blood (2000) 96 (5): 1703–1708.
https://doi.org/10.1182/blood.V96.5.1703
Published: 2000